Craig Gracey Sells Shares in Omada Health, Inc.

On June 24, 2026, Craig Gracey, the Chief Accounting Officer of Omada Health, Inc. (NasdaqGS: OMDA), sold 2,083 shares of the company. The shares were sold at an average price of $19.01, amounting to a total transaction value of $39,597.83. This sale was part of a planned transaction under Rule 10b5-1.

Insider Buying and Selling at Omada Health, Inc.

In addition to Craig Gracey's sale, other executives at Omada Health have been active. On June 26, 2026, CEO Sean Duffy sold 14,158 shares at $20.00 each. Earlier, on June 25, 2026, CFO Steven Cook and CEO Sean Duffy each sold 300 shares at $19.00. On June 24, 2026, Sean Duffy also sold 2,800 shares, and Steven Cook sold 2,600 shares at $19.01 and $19.02, respectively. These transactions were also planned.

Other Institutional Activity in Omada Health

DIVISADERO STREET CAPITAL MANAGEMENT, LP significantly increased its stake in Omada Health by adding 5,418,118 shares, bringing its total to 5,887,715 shares valued at about $74 million. Revelation Capital Management, LLC maintained its position with 5,208,034 shares worth roughly $65 million. Meanwhile, FMR LLC reduced its holdings by 1,890,124 shares, leaving it with 3,288,380 shares valued at approximately $41 million. Cigna Investments Inc /New made a slight reduction, holding 3,444,629 shares valued at $43 million.

Omada Health, Inc. Stock Down 11.8%

Shares of Omada Health, Inc. traded near $20.89 on Saturday. The company has a market capitalization of about $1.12 billion and a forward P/E ratio of 39.67. Its stock has ranged from a 52-week low of $10.28 to a high of $26.92, with a 50-day moving average of $16.29 and a 200-day moving average of $17.15. The company's current ratio is 3.92, and its quick ratio is 3.69, indicating strong liquidity.

Analysts Set New Price Targets

On June 22, 2026, Morgan Stanley reiterated a buy rating on Omada Health, setting a price target of $30. Barclays, Citizens, and Evercore ISI Group all maintained buy ratings with targets ranging from $20 to $21. Wells Fargo maintained a hold rating with an $18 target. The consensus among 12 analysts is a buy, with a mean target price of $22.92.

About Omada Health

Omada Health, Inc., based in South San Francisco, California, specializes in virtual care programs. The company offers a variety of health programs, including those for prediabetes, diabetes, hypertension, and musculoskeletal conditions, as well as behavioral health support. These services are offered to employers, health plans, and pharmacy benefits managers. Founded in 2011, Omada employs approximately 943 people and is led by CEO Sean P. Duffy.

Bottom Line

Craig Gracey's planned sale of shares is part of routine insider transactions at Omada Health, Inc. Investors often watch these moves for insights into insider sentiment. Omada Health remains a significant player in the health information services sector, with analysts maintaining a generally positive outlook. As always, remember that insider reports are historical and may not reflect current positions.